120 related articles for article (PubMed ID: 33750478)
1. The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients.
Yao J; Chen X; Liu Z; Zhang R; Zhang C; Yang Q; Yao P; Jiang Q; Wu J; Zhao S
Chin Neurosurg J; 2021 Mar; 7(1):21. PubMed ID: 33750478
[TBL] [Abstract][Full Text] [Related]
2. A Bioinformatic Analysis: The Overexpression and Prognostic Potential of
Zhao Q; Zhang L; Wang Y; Sun Y; Wang T; Cao J; Qi M; Du X; Xia Z; Zhang R; Yang Y
Int J Gen Med; 2022; 15():4321-4337. PubMed ID: 35480989
[TBL] [Abstract][Full Text] [Related]
3. ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma.
Zhang D; Wang W; Zhou H; Su L; Han X; Zhang X; Han W; Wang Y; Xue X
Front Genet; 2022; 13():851505. PubMed ID: 35711921
[No Abstract] [Full Text] [Related]
4. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
Front Oncol; 2020; 10():1119. PubMed ID: 32974125
[No Abstract] [Full Text] [Related]
5. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.
Liu Z; Zhang W; Cheng X; Wang H; Bian L; Wang J; Han Z; Wang Y; Lian X; Liu B; Ren Z; Zhang B; Jiang Z; Lin Z; Gao Y
Mol Med; 2021 May; 27(1):52. PubMed ID: 34051735
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas.
Ferreira WAS; Vitiello GAF; da Silva Medina T; de Oliveira EHC
Sci Rep; 2022 Apr; 12(1):6442. PubMed ID: 35440701
[TBL] [Abstract][Full Text] [Related]
8. GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma.
Chen Y; Tang M; Xiong J; Gao Q; Cao W; Huang J
Cancer Cell Int; 2022 Jul; 22(1):223. PubMed ID: 35790975
[TBL] [Abstract][Full Text] [Related]
9. CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells.
Wu H; Zhou Y; Wu H; Xu L; Yan Y; Tong X; Yan H
Front Genet; 2021; 12():732376. PubMed ID: 34646306
[No Abstract] [Full Text] [Related]
10. GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma.
Zhou Y; Wu H; Wang F; Xu L; Yan Y; Tong X; Yan H
Front Oncol; 2021; 11():802124. PubMed ID: 35127512
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Glutathione Peroxidases and Its Effect on Clinical Prognosis in Glioma Patients].
Ren XM; Zhang L; Xin B; Qian WW; Xia ZR; Qi M; DU XP; Shi CD; Liu QL; Zhang RQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):276-285. PubMed ID: 35538763
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of
Wang J; Liu Z; Zhang C; Wang H; Li A; Liu B; Lian X; Ren Z; Zhang W; Wang Y; Zhang B; Pang B; Gao Y
PeerJ; 2021; 9():e10820. PubMed ID: 33614284
[TBL] [Abstract][Full Text] [Related]
13. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
14. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
15. A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
Cai X; Qiu W; Qian M; Feng S; Peng C; Zhang J; Wang Y; Wang Y
Front Cell Dev Biol; 2020; 8():615970. PubMed ID: 33614625
[No Abstract] [Full Text] [Related]
16. High
Wu Z; Wang D; Zeng F; Zhang Y; Zhu G; Ma Y; Song B; Lui S; Wu M
Front Cell Dev Biol; 2021; 9():679684. PubMed ID: 34222249
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
Zhang C; Yu R; Li Z; Song H; Zang D; Deng M; Fan Y; Liu Y; Zhang Y; Qu X
Cancer Manag Res; 2019; 11():4971-4984. PubMed ID: 31213913
[No Abstract] [Full Text] [Related]
18. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
19. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
Front Oncol; 2021; 11():650534. PubMed ID: 33996568
[TBL] [Abstract][Full Text] [Related]
20. ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma.
Liu ZY; Lan T; Tang F; He YZ; Liu JS; Yang JZ; Chen X; Wang ZF; Li ZQ
BMC Cancer; 2023 May; 23(1):420. PubMed ID: 37161425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
